Imbert-Bismut, Francoise

Publishing since 1997 (Senior)

Has published 36 publications in 13 years

Number of publications published per year by Imbert-Bismut, Francoise. (Source : PubMed)

Distribution of publications types for Imbert-Bismut, Francoise. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Munteanu M, Lebray P, Massard J, Moussalli J, Varaut A, Ngo Y, Thabut D, Imbert-Bismut F, Benhamou Y, Ratziu V, Poynard T. Discordance between results of biomarkers of fibrosis shows that it is at least a "ménage à deux".  Gastroenterol. Clin. Biol.  2009;33;2  
•  Imbert-Bismut F, Naveau S, Morra R, Munteanu M, Ratziu V, Abella A, Messous D, Thabut D, Benhamou Y, Poynard T. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption.  Eur J Gastroenterol Hepatol  2009;21;1  
•  Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Assessment of liver fibrosis: noninvasive means.  Saudi J Gastroenterol  2008;14;4  
•  Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, Messous D, Massard J, Lebray P, Moussalli J, Benhamou Y, Ratziu V. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.  Gastroenterol. Clin. Biol.  2008;32;6 Suppl 1  
•  Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, Bernard M, Hartemann-Heurtier A, Imbert-Bismut F, Ratziu V, Grimaldi A, Poynard T. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.  Clin. Gastroenterol. Hepatol.  2008;6;7  
•  Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.  J Gastrointestin Liver Dis  2008;17;2  
•  Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H, Ferard G. The use of enzyme results for liver fibrosis evaluation neccessitates standardization.  Hepatology  2008;47;3  
•  Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Bonnefont-Rousselot D, Rousselot-Bonnefont D, Moussalli J, Ratziu V, Poynard T. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.  PLoS ONE  2008;3;7  
•  Rosenthal-Allieri MA, Tran A, Halfon P, Imbert-Bismut F, Munteanu M, Messous D, Peritore ML, Poynard T, Bernard A. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.  Gastroenterol. Clin. Biol.  2007;31;10  
•  Morra R, Munteanu M, Bedossa P, Dargere D, Janneau JL, Paradis V, Ratziu V, Charlotte F, Thibault V, Imbert-Bismut F, Poynard T. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.  Aliment. Pharmacol. Ther.  2007;26;6  

[ See timeline ] [ See all publications ]